• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD ACCESS SYSTEMS SM ATT PLAS+8FR GROSH+KI; IMPLANTABLE PORT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD ACCESS SYSTEMS SM ATT PLAS+8FR GROSH+KI; IMPLANTABLE PORT Back to Search Results
Model Number 0602830
Device Problem Fluid/Blood Leak (1250)
Patient Problems Extravasation (1842); Caustic/Chemical Burns (2549)
Event Date 06/07/2019
Event Type  Injury  
Manufacturer Narrative
As the lot number for the device was provided, a review of the device history records is currently being performed.The device has been returned to the manufacturer for evaluation.The investigation of the reported event is currently underway.Medical device - expiration date: 01/2023.
 
Event Description
It was reported that approximately one year post port device implant, the port allegedly leaked chemotherapy fluid and caused a burn.It was further reported that the port device was removed and a new port device was implanted.The patient status is unknown.
 
Event Description
It was reported that approximately one year post port device implant, during chemotherapy, an alleged port leak was identified, resulting in a burning sensation at an unknown location.It was further reported that the port device was removed and a new port device was implanted.The patient status is unknown.
 
Manufacturer Narrative
Manufacturing review: the lot met all release criteria.Dhr was reviewed and no deviations/issues were identified or associated with this problem in regards to product materials or during manufacturing, packaging or qc inspection process.Ll necessary inspections were performed throughout all manufacturing, packaging and inspection activities and for raw material utilized in the manufacture of this lot in regards to the described problem.Labeling review: a review of product labeling documents (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, nursing guide, and unit label) showed that the product labeling is adequate.Investigation summary: one mri port with groshong catheter, the catheter being cut into two pieces with the proximal part still attached to the port using the cathlock, was returned for evaluation.The complete circumferential break was noted approximately 4.4cm from the distal end of the cath-lock and appeared to be cut using an instrument.A circumferential split was noted on the distal segment of the catheter.Functional evaluations were performed and both port body and catheter segments were patent with a leak observed at the circumferential split.The investigation is confirmed for the alleged leak, as a leaking circumferential split was noted at approximately 3.3cm from the proximal end of the distal segment.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SM ATT PLAS+8FR GROSH+KI
Type of Device
IMPLANTABLE PORT
Manufacturer (Section D)
BARD ACCESS SYSTEMS
605 n. 5600 w.
salt lake city UT 84116
MDR Report Key8896807
MDR Text Key154419185
Report Number3006260740-2019-02402
Device Sequence Number1
Product Code LJT
UDI-Device Identifier00801741025716
UDI-Public(01)00801741025716
Combination Product (y/n)N
PMA/PMN Number
K873213
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type user facility
Type of Report Initial,Followup
Report Date 12/26/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number0602830
Device Catalogue Number0602830
Device Lot NumberRECP0272
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/30/2019
Initial Date Manufacturer Received 07/23/2019
Initial Date FDA Received08/15/2019
Supplement Dates Manufacturer Received12/24/2019
Supplement Dates FDA Received12/26/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
CHEMOTHERAPY FLUID; CHEMOTHERAPY FLUID
Patient Outcome(s) Other; Required Intervention;
Patient Age53 YR
-
-